Information about the Ludwig Boltzmann Institute for Hematology and Oncology (formerly Ludwig Boltzmann Cluster Oncology)
Structure and Organization
The Ludwig Boltzmann Institute for Hematology and Oncology consists of a team of high-ranking scientists.
On a scientific level, the Institute for Hematology and Oncology is coordinated by Univ.-Prof. Dr. Peter Valent and his deputy Univ.-Prof. Dr. Thomas Grunt, on the administrative level by Dr. med. vet. Emir Hadzijusufovic.
The local Scientific Advisory Board consists of the following members:
- Univ.-Prof. Dr. Ulrich Jäger
- Univ.-Prof. Dr. Hubert Pehamberger
- Univ.-Prof. Dr. Oswald Wagner
- Univ.-Prof. Dr. Christoph Zielinski
Scientific projects on tumor stem cells for myeloid leukemias, lymphatic leukemias, solid tumors* and melanomas* are part of the LBI HO program.
The infrastructure for the scientific projects is ensured by 5 platforms covering the fields of flow cytometry, gene expression profiling, mouse model analysis, clinical applications as well as public relations including training and advanced training.
The projects of the institute are supported by numerous funding agencies, the core consortium is sponsored by the Ludwig Boltzmann Gesellschaft.
*Based on the evaluation in 2010, the “Solid Tumors” program line was discontinued in 2011 and the “Melanoma” program line was transformed into the new “Mastocytosis and Mast Cell Leukemia” program line.
Duties and Aims
The tasks of the Institute for Hematology and Oncology are derived from the successful collaboration of preclinical basic research and clinical medicine in the field of tumor stem cell research.
Molecular cell and tissue research results are being implemented in the development of new strategies for cancer and leukemia treatment.
The research objectives are determined by new concepts for clinical applications that are the outcome of results from our in vitro studies.
The overarching goal of the LBI HO is to develop new therapeutic concepts in cancer research aiming at eliminating cancer stem cells in leukemias and solid tumors.
The Ludwig Boltzmann Institute for Hematology and Oncology started in 2008 with a total of 6 employees including one administrative assistant. Currently, the LBI HO employs 12 people.
All other personnel resources required for the institute projects are covered by the partner cooperations (Medical University of Vienna, University of Veterinary Medicine Vienna and Hanusch Hospital). The management of the institute and the core facilities is also carried out in cooperation with the partners.
A key goal in the development of personnel in the LBI HO is the career development at the level of the academic carrier (scientists). The management of the LBI HO is committed to give scientists the opportunity to develop in their environment and research area to the maximum and to learn all relevant techniques. In addition, the process of project development, the development of scientific concepts and the presentation of data are trained and promoted. The ultimate goal is the creation of viable new concepts and solid first author manuscripts. Strategic long-term goals are above all the preparation of habilitations and the independent development of projects and project-specific environmental work (applications, group management, strategic planning, management of cooperation projects, etc).
The following specific objectives have been implemented since 2008:
- Sorting courses for the LBI HO team
- Networking with the doctoral program of the MedUni Vienna
- Post-seminar round table series – collaboration reviews
- Regular project development meetings
- Regular small group meetings
- Regular manuscript reviews
The LBI HO is actively promoting young talents. Several PhD and diploma theses are currently ongoing, new ones are starting continuously. The LBI HO and its partner institutions are also constantly looking for new employees and interested students who would like to start a scientific career in the field of oncology.